Orient Pharma Market Cap

Orient Pharma has a market cap or net worth of 6.71 billion as of May 1, 2025. Its market cap has increased by 40.00% in one year.

Market Cap

6.71B

Enterprise Value

7.15B

Revenue

1.22B

Ranking

n/a

PE Ratio

62.52

Stock Price

30.10

Market Cap Chart

Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.71B, an increase of 63.10%. That is a compound annual growth rate of 3.87%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2025	6.71B	-16.39%
Dec 31, 2024	8.03B	80.00%
Dec 29, 2023	4.46B	14.13%
Dec 30, 2022	3.91B	11.76%
Dec 30, 2021	3.50B	28.52%
Dec 31, 2020	2.72B	20.11%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	174.85B
Caliway Biopharmaceuticals	103.28B
Bora Pharmaceuticals Co., LTD.	73.22B
Lotus Pharmaceutical	57.54B
Oneness Biotech	29.88B
Polaris Group	28.35B
Lumosa Therapeutics	27.61B
Pegavision	27.14B

Market Cap Rankings